Tedisamil has been described as a selective inhibitor of a fast inactivating transient outward current (i(to,f)) in rat ventricular myocytes. Because recent reports demonstrated the existence of a second slowly inactivating transient component (i(to,s)) we investigated i(to,s) and differentiated the effects of tedisamil on both transient outward current components and their influence on action potential duration. Standard electrophysiological techniques were used for whole cell recordings at 24-26 degrees C from enzymatically isolated myocytes. Inhibition of i(to,f) by tedisamil was the result of an acceleration of inactivation at positive test potentials with a concentration for half-maximal inhibition (EC50) of 4-7 micromol/l, which is confirmatory to reports from other investigators. Our new results show that i(to,s) is more sensitive to tedisamil with an EC50 of 0.5 micromol/l. Furthermore the pattern of i(to,s) inhibition is different compared with i(to,f), because inactivation of i(to,s) is not accelerated by tedisamil. Instead the amplitude of the steady state inactivation curve of i(to,s) is attenuated which indicates a reduction of maximally available current. I(to,s) was evaluated by three different methods as time-dependently inactivating current (7.5 s test pulse duration), voltage-dependently inactivated current and tedisamil-sensitive current. All approaches yield similar inactivation curves. The potential for halfmaximal inactivation of i(to,s) lies about 35 mV more negative than that for i(to,f) and the slope factor (K = -23 mV) is different to that of i(to,f) (K = -3 mV). Effectiveness of tedisamil-induced modulation of i(to,f) and i(to,s) on action potential repolarization was tested. Action potentials stimulated at 0.5 Hz were not prolonged by 1 micromol/l tedisamil (dominant i(to,s) block) at a repolarization level of 0 mV but prolonged to about 120% of control at -70 mV. This indicates that i(to,f) was sufficient to guarantee a regular early repolarization whereas decrease of i(to,s) delayed the final repolarization. In conclusion, the observation that tedisamil inhibits i(to,f) and i(to,s) differently supports the hypothesis that the two i(to)-components are related to two different channel populations expressed in rat ventricular myocytes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/pl00005170DOI Listing

Publication Analysis

Top Keywords

inactivating transient
12
transient outward
12
outward current
12
rat ventricular
12
ventricular myocytes
12
itos
12
tedisamil
8
slowly inactivating
8
itof
8
action potential
8

Similar Publications

Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.

bioRxiv

January 2025

Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Background And Purpose: Polycystins (PKD2, PKD2L1) are voltage-gated and Ca-modulated members of the transient receptor potential (TRP) family of ion channels. Loss of PKD2L1 expression results in seizure-susceptibility and autism-like features in mice, whereas variants in PKD2 cause autosomal dominant polycystic kidney disease. Despite decades of evidence clearly linking their dysfunction to human disease and demonstrating their physiological importance in the brain and kidneys, the polycystin pharmacophore remains undefined.

View Article and Find Full Text PDF

The methylotrophic yeast belongs to the group of homothallic fungi that are able to spontaneously change their mating type by inversion of chromosomal DNA in the MAT locus region. As a result, natural and genetically engineered cultures of these yeasts typically contain a mixture of sexually dimorphic cells that are prone to self-diploidisation and spore formation accompanied by genetic rearrangements. These characteristics pose a significant challenge to the development of genetically stable producers for industrial use.

View Article and Find Full Text PDF

To investigate the safety of the tetravalent meningococcal conjugate vaccine (MPCV-ACYW) in combination with the inactivated poliomyelitis (IPV) vaccine and diphtheria-tetanus-acellular pertussis (DTaP) vaccine for infants aged 3-5 months and provide real-world evidence for the immunization strategy of vaccine combination. From June to October 2023, a total of 600 3-month-old infants were selected and divided into three groups: control group, mono-vaccination group and combined vaccination group. They were simultaneously or individually vaccinated with MPCV-ACYW, IPV and DTaP vaccines at 3, 4, and 5 months of age, respectively.

View Article and Find Full Text PDF

A splice donor in influences keratinocyte immortalization by beta-HPV49.

J Virol

January 2025

Institute for Medical Virology and Epidemiology of Viral Diseases, University of Tuebingen, Tuebingen, Germany.

Human papillomaviruses (HPV) from the genus beta have been implicated in the development of cutaneous squamous cell cancer in and organ transplant patients. In contrast to alpha-high-risk HPV, which cause ano-genital and oropharyngeal cancers, beta-HPV replication is not well understood. The beta-HPV49 transcriptome was analyzed by RNA sequencing using stable keratinocyte cell lines maintaining high levels of extrachromosomally replicating E8- genomes, which can be established due to a lack of the viral E8^E2 repressor protein.

View Article and Find Full Text PDF

Transient activation of YAP/TAZ confers resistance to morusin-induced apoptosis.

BMC Mol Cell Biol

January 2025

Department of Biological Sciences, Sungkyunkwan University, Suwon, 16419, Republic of Korea.

Background: The Hippo signaling pathway involves a kinase cascade that controls phosphorylation of the effector proteins YAP and TAZ, leading to regulation of cell growth, tissue homeostasis, and apoptosis. Morusin, a compound extracted from Morus alba, has shown potential in cancer therapy by targeting multiple signaling pathways, including the PI3K/Akt/mTOR, JAK/STAT, MAPK/ERK, and apoptosis pathways. This study explores the effects of morusin on YAP activation and its implications for apoptosis resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!